What Researchers Did
Researchers presented a case report of a 55-year-old man with long COVID who was successfully treated with hyperbaric oxygen therapy.
What They Found
The patient, suffering from long COVID for 3 months, underwent 60 sessions of hyperbaric oxygen therapy, each lasting 90 minutes.
Post-treatment evaluation revealed significant improvements in his memory, multitasking, energy, breathing, and physical fitness, alongside enhanced brain perfusion.
What This Means for Canadian Patients
This case report offers preliminary evidence that hyperbaric oxygen therapy could potentially alleviate persistent long COVID symptoms.
However, further robust clinical trials are essential before this treatment can be considered for widespread use among Canadian patients.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The findings of this study are limited by its nature as a single case report, preventing generalizability to a larger patient population.